Market closedADR

AstraZeneca/$AZN

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About AstraZeneca

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.

Ticker

$AZN

Sector

Health Care

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Cambridge, United Kingdom

Employees

89,900

Website

www.astrazeneca.com

AstraZeneca Metrics

BasicAdvanced

$205B

15.84 $4.15

0.18 $1.46

1.49%

Price and volume

Market cap

$205B

Beta

0.18

52-week high

$87.01

52-week low

$60.47

Average daily volume

4.9M

Dividend rate

$1.46

Financial strength

Current ratio

0.932

Quick ratio

0.713

Long term debt to equity

73.584

Total debt to equity

77.473

Dividend payout ratio (TTM)

71.25%

Interest coverage (TTM)

10.12%

Management effectiveness

Return on assets (TTM)

8.50%

Return on equity (TTM)

16.66%

Valuation

Price to earnings (TTM)

15.838

Price to revenue (TTM)

1.989

Price to book

4.12

Price to tangible book (TTM)

-8.47

Price to free cash flow (TTM)

14.834

Dividend yield (TTM)

2.21%

Forward dividend yield

1.49%

Growth

Revenue change (TTM)

13.81%

Earnings per share change (TTM)

9.79%

3-year revenue growth (CAGR)

15.99%

3-year earnings per share growth (CAGR)

56.50%

3-year dividend per share growth (CAGR)

1.98%

What the Analysts think about AstraZeneca

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for AstraZeneca stock.

AstraZeneca Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

AstraZeneca Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

AstraZeneca News

AllArticlesVideos

February 21, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against AZN

Accesswire·7 hours ago

February 21, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against AZN

Accesswire·8 hours ago

AstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - AZN

Accesswire·9 hours ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AZN

$

Capital at risk

Market closedADR

Upcoming events

No upcoming events

FAQs

What’s the current market cap for AstraZeneca stock?

AstraZeneca (AZN) has a market cap of $205B as of January 15, 2025.

What is the P/E ratio for AstraZeneca stock?

The price to earnings (P/E) ratio for AstraZeneca (AZN) stock is 15.84 as of January 15, 2025.

Does AstraZeneca stock pay dividends?

Yes, the AstraZeneca (AZN) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $1.455 and the yield is 1.49%. AstraZeneca has a payout ratio of 71.25% on a trailing twelve-month basis.

When is the next AstraZeneca dividend payment date?

The next AstraZeneca (AZN) dividend payment date is unconfirmed.

What is the beta indicator for AstraZeneca?

AstraZeneca (AZN) has a beta rating of 0.18. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.